|1.||Tripathi, Rama P: 2 articles (07/2014 - 01/2006)|
|2.||Yuan, Wei-Cheng: 1 article (06/2015)|
|3.||Cui, Bao-Dong: 1 article (06/2015)|
|4.||Zhang, Xiao-Mei: 1 article (06/2015)|
|5.||Xu, Xiao-Ying: 1 article (06/2015)|
|6.||You, Yong: 1 article (06/2015)|
|7.||Zhou, Ming-Qiang: 1 article (06/2015)|
|8.||Zuo, Jian: 1 article (06/2015)|
|9.||Zhao, Jian-Qiang: 1 article (06/2015)|
|10.||Devender, N: 1 article (07/2014)|
|1.||Astrocytoma (Pilocytic Astrocytoma)
07/01/1996 - "In this study, r in the astrocytoma cells labeled with 1-(4-trimethylammonium phenyl)-6-phenyl-1,3,5-hexatriene p-toluenesulfonate was shown to remain stable for up to 90 min. However, when the cells were treated with 75 microM iodoacetic acid (IAA), a metabolic inhibitor that induces rapid depletion of cellular ATP, r continually decreased, indicating a decrease in membrane lipid order and perturbation of the bilayer structure. "
|2.||Dehydration (Water Stress)
07/23/2014 - "The two of these pyrrolinones on dehydration with p-toluenesulfonic acid, were transformed into γ-(triazolyl ethylidene)pyrrolinones (34, 35). "
12/01/1996 - "Hydroxyindolones (1-6, 15-16) were transformed into isatinylidenes (7, 9-13, 17-19) by dehydration with 4-toluenesulfonic acid. "
06/01/2007 - "5-Ethylchrysene was synthesized by reaction of 5-keto-5,6,6a,7,8,9,10,10a-octahydrochrysene with CH3CH2MgBr followed by dehydration catalyzed by p-toluenesulfonic acid and dehydrogenation with DDQ in benzene. "
01/01/2006 - "Subsequent dehydration of the hydroxy lactams with p-toluene sulphonic acid afforded the dienyl tetramic acid derivatives. "
06/05/2015 - "The reactions were catalyzed by diphenylprolinol silyl ether and 2-fluorobenzoic acid via an asymmetric Michael/Friedel-Crafts cascade process, followed by dehydration with p-toluenesulfonic acid to afford a wide variety of structurally diverse spiro[5,6-dihydropyrido[1,2-a]pyrrole-3,3'-oxindole] derivatives in high yields (up to 93%) and with high to excellent diastereo- and enantioselectivities (up to >99:1 dr and 97% ee). "
|3.||Liver Diseases (Liver Disease)
07/01/1992 - "The development of stable double salt of p-toluene sulphonic acid and sulphuric acid of SAMe enables the clinical use of the drug, as a therapeutical agent, for the treatment of a number of liver dysfunctions. "
09/15/1960 - "[The precipitation reaction to p-toluenesulfonic acid in liver diseases]."
|5.||BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
|2.||Adenosine Triphosphate (ATP)
|3.||benzenesulfonic acid (benzenesulfonate)
|4.||Methacholine Chloride (Methacholine)
|9.||diphenylprolinol silyl ether